Literature DB >> 2044206

Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

F B Taylor1, A Chang, W Ruf, J H Morrissey, L Hinshaw, R Catlett, K Blick, T S Edgington.   

Abstract

Gram-negative bacteremia poses a major health problem, causing one-half of cases of lethal septic shock acquired during hospitalization. Bacterial lipopolysaccharide (LPS) and the inflammatory cytokines, tumor necrosis factor (TNF) and interleukin-1 (IL-1), have been shown to be essential mediators of septic shock. Among the effects of these mediators is a coagulopathy that may be triggered by induced expression of tissue factor (TF) on macrophages and endothelial cells. We now report that 500 micrograms/kg of either immunoglobulin G (IgG) or Fab fragments of a monoclonal antibody against TF administered to baboons as a pretreatment attenuates the coagulopathy and protects against LD100 Escherichia coli. This study provides direct evidence of an essential effector role for TF in septic shock.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044206

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  103 in total

1.  Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.

Authors:  M Riewald; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Lipopolysaccharide induction of tissue factor expression in rabbits.

Authors:  J Erlich; C Fearns; J Mathison; R J Ulevitch; N Mackman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

4.  Role of NFkappaB in the mortality of sepsis.

Authors:  H Böhrer; F Qiu; T Zimmermann; Y Zhang; T Jllmer; D Männel; B W Böttiger; D M Stern; R Waldherr; H D Saeger; R Ziegler; A Bierhaus; E Martin; P P Nawroth
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 5.  Emerging therapies in severe sepsis.

Authors:  S J Finney; T W Evans
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 6.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

7.  Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.

Authors:  Florry E van den Boogaard; Cornelis van 't Veer; Joris J T H Roelofs; Joost C M Meijers; Marcus J Schultz; George J Broze; Tom van der Poll
Journal:  Thromb Haemost       Date:  2015-04-02       Impact factor: 5.249

8.  Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

9.  Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.

Authors:  T A Drake; J Cheng; A Chang; F B Taylor
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.

Authors:  Frank Niessen; Christian Furlan-Freguia; José A Fernández; Laurent O Mosnier; Francis J Castellino; Hartmut Weiler; Hugh Rosen; John H Griffin; Wolfram Ruf
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.